Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eyegate Pharma (EYEG)

Eyegate Pharma (EYEG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,887
  • Shares Outstanding, K 7,098
  • Annual Sales, $ 10 K
  • Annual Income, $ -8,090 K
  • 60-Month Beta 1.13
  • Price/Sales 1,715.33
  • Price/Cash Flow N/A
  • Price/Book 1.62
Trade EYEG with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.42
  • Number of Estimates 2
  • High Estimate -0.42
  • Low Estimate -0.42
  • Prior Year -0.38
  • Growth Rate Est. (year over year) -10.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.35 +2.55%
on 08/02/21
6.43 -62.52%
on 07/27/21
-1.22 (-33.61%)
since 07/02/21
3-Month
2.35 +2.55%
on 08/02/21
6.43 -62.52%
on 07/27/21
-1.82 (-43.03%)
since 04/30/21
52-Week
2.35 +2.55%
on 08/02/21
8.18 -70.54%
on 12/21/20
-1.67 (-40.93%)
since 07/31/20

Most Recent Stories

More News
Thinking about buying stock in Verb Technology, Sundial Growers, Eyegate Pharmaceuticals, American Airlines, or Zomedica?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VERB, SNDL, EYEG, AAL, and ZOM.

ZOM : 0.6243 (+2.61%)
AAL : 20.06 (-1.57%)
SNDL : 0.8145 (-1.26%)
VERB : 2.45 (+5.15%)
EYEG : 2.41 (-4.37%)
EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business Update

WALTHAM, MA / ACCESSWIRE / November 9, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of...

EYEG : 2.41 (-4.37%)
EyeGate Pharma Confirms Path Forward with FDA To Develop Combination Product

WALTHAM, MA / ACCESSWIRE / August 12, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of...

EYEG : 2.41 (-4.37%)
EyeGate Pharma Reports Second Quarter 2020 Financial Results and Provides Business Update

WALTHAM, MA / ACCESSWIRE / August 6, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the...

EYEG : 2.41 (-4.37%)
EyeGate Pharma Receives Positive Feedback from FDA Regarding Ocular Bandage Gel Packaging

WALTHAM, MA / ACCESSWIRE / June 11, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the...

EYEG : 2.41 (-4.37%)
EyeGate Pharma to Present at Jefferies 2020 Virtual Healthcare Conference

WALTHAM, MA / ACCESSWIRE / June 1, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the...

EYEG : 2.41 (-4.37%)
EyeGate Pharma Reports First Quarter 2020 Financial Results and Provides Business Update

WALTHAM, MA / ACCESSWIRE / May 6, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the...

EYEG : 2.41 (-4.37%)
Company News for Apr 1, 2020

Companies In The News Are: KNSA, EYEG, VBIV, EYES

EYES : 3.91 (+2.36%)
EYEG : 2.41 (-4.37%)
VBIV : 3.03 (+1.68%)
KNSA : 16.23 (+5.87%)
EyeGate Pharma Announces Positive Topline Data in Follow-on Dry Eye Pilot Study

WALTHAM, MA / ACCESSWIRE / March 31, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the...

EYEG : 2.41 (-4.37%)
EyeGate Pharma Reports Full Year 2019 Financial Results and Provides Business Update

WALTHAM, MA / ACCESSWIRE / March 4, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the...

EYEG : 2.41 (-4.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

EyeGate Pharmaceuticals, Inc. is a pharmaceutical company which is engaged in developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The company's technology consists of EyeGate(R) II Delivery System. Its product pipeline includes EGP-437 which is in different...

See More

Key Turning Points

3rd Resistance Point 2.79
2nd Resistance Point 2.69
1st Resistance Point 2.55
Last Price 2.41
1st Support Level 2.31
2nd Support Level 2.21
3rd Support Level 2.07

See More

52-Week High 8.18
Fibonacci 61.8% 5.95
Fibonacci 50% 5.27
Fibonacci 38.2% 4.58
Last Price 2.41
52-Week Low 2.35

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar